These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6169360

  • 1. Oncofoetal antigens in cancer of the cervix and ovary.
    Cauchi MN, Koh SH, Lim D, Hay DL.
    Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL, Purnell DM, Combs JW, Hillman EA, Harris CC, Trump BF.
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [Abstract] [Full Text] [Related]

  • 3. Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
    Bychkov V, Rothman M, Bardawil WA.
    Am J Clin Pathol; 1983 Apr; 79(4):414-20. PubMed ID: 6188359
    [Abstract] [Full Text] [Related]

  • 4. Immunologic monitoring of cervical carcinoma.
    Almerigogna F, Borri P, Buzzoni P, Locatelli F, Savino L.
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):164-7. PubMed ID: 6176450
    [No Abstract] [Full Text] [Related]

  • 5. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
    Kimura N, Ghandur-Mnaymen L.
    Tohoku J Exp Med; 1985 Jan; 145(1):23-38. PubMed ID: 2580364
    [Abstract] [Full Text] [Related]

  • 6. Tumor markers in the ovarian carcinoma.
    Margariti PA, Benedetti Panici P, Villani L, Di Roberto P, Maiorca A, Sacco F, Bompiani A.
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of oncofetal antigens in patients with ovarian cancer.
    Koh SH, Cauchi MN.
    Aust N Z J Obstet Gynaecol; 1983 May; 23(2):69-72. PubMed ID: 6194783
    [Abstract] [Full Text] [Related]

  • 8. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH, Koh SH, Hay DL, Cauchi MN.
    Gynecol Obstet Invest; 1984 May; 18(3):117-21. PubMed ID: 6208091
    [Abstract] [Full Text] [Related]

  • 9. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
    Sacco F, Benedetti Panici P, Margariti PA, Di Roberto P, Maiorca A, Muscatello P, Villani L, Iacobelli S.
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
    [No Abstract] [Full Text] [Related]

  • 10. Multiple biochemical markers in patients with gynecologic malignancies.
    Donaldson ES, van Nagell JR, Pursell S, Gay EC, Meeker WR, Kashmiri R, van deVoorde J.
    Cancer; 1980 Mar 01; 45(5):948-53. PubMed ID: 6167342
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
    Williams RR, McIntire KR, Waldmann TA, Feinleib M, Go VL, Kannel WB, Dawber TR, Castelli WP, McNamara PM.
    J Natl Cancer Inst; 1977 Jun 01; 58(6):1547-51. PubMed ID: 68118
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of cellular change to malignancy by tissue localization of blood group antigens, A, B, O(H) and carcino-fetal proteins (CEA, HCG)].
    Kodama S.
    Nihon Gan Chiryo Gakkai Shi; 1983 Dec 20; 18(8):1987-97. PubMed ID: 6674403
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistological study of isoantigens, carcinoembryonic antigen and human chorionic gonadotropin in adenocarcinomas of the uterus.
    Ueda G, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Inoue Y, Saito J, Nishino T, Kurachi K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Mar 20; 36(3):437-42. PubMed ID: 6715926
    [Abstract] [Full Text] [Related]

  • 16. A survey of tumor markers in patients with squamous cell carcinoma of the uterine cervix.
    Fritsche HA, Freedman RS, Liu F, Acomb LD, Collinsworth WL.
    Gynecol Oncol; 1982 Oct 20; 14(2):230-5. PubMed ID: 6182055
    [No Abstract] [Full Text] [Related]

  • 17. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
    Martínez L, Castilla JA, Blanco N, Perán F, Herruzo A.
    Int J Gynaecol Obstet; 1995 Feb 20; 48(2):187-92. PubMed ID: 7540567
    [Abstract] [Full Text] [Related]

  • 18. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
    Harach HR, Skinner M, Gibbs AR.
    Thorax; 1983 Dec 20; 38(12):937-41. PubMed ID: 6198740
    [Abstract] [Full Text] [Related]

  • 19. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ.
    Clin Obstet Gynecol; 1975 Dec 20; 18(4):87-108. PubMed ID: 765038
    [Abstract] [Full Text] [Related]

  • 20. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
    Tottori K, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan 20; 33(1):142-50. PubMed ID: 6164739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.